144 related articles for article (PubMed ID: 22174603)
1. Antiproliferative effect of aaptamine on human chronic myeloid leukemia K562 cells.
Jin M; Zhao W; Zhang Y; Kobayashi M; Duan H; Kong D
Int J Mol Sci; 2011; 12(11):7352-9. PubMed ID: 22174603
[TBL] [Abstract][Full Text] [Related]
2. Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner.
Aoki S; Kong D; Suna H; Sowa Y; Sakai T; Setiawan A; Kobayashi M
Biochem Biophys Res Commun; 2006 Mar; 342(1):101-6. PubMed ID: 16480688
[TBL] [Abstract][Full Text] [Related]
3. [Experimental research on tyrosine-kinase inhibitor STI571 and P21WAF gene clone to treat chronic myeloid leukemia].
Wang W; Sun BZ; Liu XP; Feng Q; Shang ZC; Cao YX; Yao LB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):737-42. PubMed ID: 15631651
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity.
Dyshlovoy SA; Naeth I; Venz S; Preukschas M; Sievert H; Jacobsen C; Shubina LK; Gesell Salazar M; Scharf C; Walther R; Krepstakies M; Priyadarshini P; Hauber J; Fedorov SN; Bokemeyer C; Stonik VA; Balabanov S; Honecker F
J Proteome Res; 2012 Apr; 11(4):2316-30. PubMed ID: 22409352
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxic and mechanistic effects of aaptamine on hepatocellular carcinoma.
Li QL; Zhang PP; Wang PQ; Yu HB; Sun F; Hu WZ; Wu WH; Zhang X; Chen F; Chu ZY; Zhang JP; Chen SS; Lin HW
Anticancer Agents Med Chem; 2015; 15(3):291-7. PubMed ID: 25403168
[TBL] [Abstract][Full Text] [Related]
6. A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib.
Yandim MK; Ceylan C; Elmas E; Baran Y
Tumour Biol; 2016 Feb; 37(2):2365-78. PubMed ID: 26373734
[TBL] [Abstract][Full Text] [Related]
7. A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb.
Zhang B; Zhang T; Zhang TY; Wang N; He S; Wu B; Jin HX
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708403
[TBL] [Abstract][Full Text] [Related]
8. Three new aaptamine derivatives from the South China Sea sponge Aaptos aaptos.
Gan JH; Hu WZ; Yu HB; Yang F; Cao MX; Shi HJ; Kang YF; Han BN
J Asian Nat Prod Res; 2015; 17(12):1231-8. PubMed ID: 26699877
[TBL] [Abstract][Full Text] [Related]
9. Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells.
Chen Y; Zhou Q; Zhang L; Wang R; Jin M; Qiu Y; Kong D
Oncol Rep; 2016 Dec; 36(6):3643-3650. PubMed ID: 27748929
[TBL] [Abstract][Full Text] [Related]
10. HIF-α Promotes Chronic Myelogenous Leukemia Cell Proliferation by Upregulating p21 Expression.
Chen H; Shen Y; Gong F; Jiang Y; Zhang R
Cell Biochem Biophys; 2015 May; 72(1):179-83. PubMed ID: 25596666
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells.
Zhou Q; Chen Y; Chen X; Zhao W; Zhong Y; Wang R; Jin M; Qiu Y; Kong D
Int J Biol Sci; 2016; 12(6):631-8. PubMed ID: 27194941
[TBL] [Abstract][Full Text] [Related]
12. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C
Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia.
Li J; Xue L; Hao H; Han Y; Yang J; Luo J
Oncol Rep; 2012 Feb; 27(2):461-6. PubMed ID: 21993902
[TBL] [Abstract][Full Text] [Related]
14. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562.
Pal P; Kanaujiya JK; Lochab S; Tripathi SB; Bhatt ML; Singh PK; Sanyal S; Trivedi AK
Proteomics; 2011 Apr; 11(8):1517-29. PubMed ID: 21360677
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
[TBL] [Abstract][Full Text] [Related]
16. Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells.
Li H; Hui H; Xu J; Yang H; Zhang X; Liu X; Zhou Y; Li Z; Guo Q; Lu N
Arch Toxicol; 2016 Jun; 90(6):1507-22. PubMed ID: 26104856
[TBL] [Abstract][Full Text] [Related]
17. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic aaptamine derivatives from the South China Sea sponge Aaptos aaptos.
Yu HB; Yang F; Sun F; Ma GY; Gan JH; Hu WZ; Han BN; Jiao WH; Lin HW
J Nat Prod; 2014 Sep; 77(9):2124-9. PubMed ID: 25211032
[TBL] [Abstract][Full Text] [Related]
19. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
[TBL] [Abstract][Full Text] [Related]
20. p21(Cip1) confers resistance to imatinib in human chronic myeloid leukemia cells.
Ferrandiz N; Caraballo JM; Albajar M; Gomez-Casares MT; Lopez-Jorge CE; Blanco R; Delgado MD; Leon J
Cancer Lett; 2010 Jun; 292(1):133-9. PubMed ID: 20042273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
